1-3 of 3
Leena Chaudhuri, PhD
Close
Sort by
Journal Articles

The Wee1 Inhibitor MK1775 In Combination With Cytarabine (AraC) Has Potent Activity In AML By Completely Abrogating DNA Damage and Cell Cycle Checkpoint Repair Capacity Via The Mrn/NBS1 Complex

Leena Chaudhuri, PhD, James M Bogenberger, PhD, Lisa Sproat, MD, MSW, James L Slack, MD, Veena Fauble, MD, Raoul Tibes, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3831.
https://doi.org/10.1182/blood.V122.21.3831.3831
Published: 2013
Journal Articles

BH3 Profiling As Predictor Of 5-Azacytidine and Decitabine Clinical Responses

Raoul Tibes, MD, PhD, Steven M. Kornblau, MD, William E. Pierceall, PhD, Ryan Lena, BS, Yi Hua Qiu, MD, Michael Cardone, PhD, Leena Chaudhuri, PhD, Veena Fauble, MD, Michael Elashoff, Noel Blake, B.S., Ruben A. Mesa, MD, James M Bogenberger, PhD
Journal: Blood
Blood (2013) 122 (21): 603.
https://doi.org/10.1182/blood.V122.21.603.603
Published: 2013
Journal Articles

RNAi Screening of the Human Kinome Identifies Inhibition of WEE1 Kinase As Potent and Universal Sensitizing Target to Cytarabine in Leukemias

Raoul Tibes, MD, PhD, Leena Chaudhuri, PhD, James M Bogenberger, PhD, Tanner R Hagelstrom, PhD, MBA, Amanda McNally, MS, Donald Chow, Megan E Buechel, MS, Irma Gonzales, Esteban Braggio, PhD, Hongwei Yin, PHD, Shilpi Arora, PhD, David Azorsa, PhD, Craig B. Reeder, MD, Pierre Noel, MD, James L. Slack, MD, Ruben A. Mesa, MD, Tim Demuth, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 229.
https://doi.org/10.1182/blood.V118.21.229.229
Published: 2011